ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.630,44
0,41%
S&P 500
5.487,03
0,25%
US Dollar vs BRL
5,4415
0,00%
Bitcoin
65.215,88
0,12%
Brent Oil
84,705
-0,09%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Fulgent Genetics Inc (FLGT)

  7. Fulgent Genetics Inc (FLGT) Notícias

FLGT

Fulgent Genetics (FLGT)

Fulgent Genetics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FLGT
DataHoraFonteTítuloCódigoCompanhia
04/06/202417:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
03/06/202409:00Business WireFulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck CancerNASDAQ:FLGTFulgent Genetics Inc
24/05/202409:00Business WireFulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
16/05/202417:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FLGTFulgent Genetics Inc
14/05/202417:05Business WireMoffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer TherapeuticsNASDAQ:FLGTFulgent Genetics Inc
03/05/202408:00Business WireFulgent Reports First Quarter 2024 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
11/04/202417:05Business WireFulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024NASDAQ:FLGTFulgent Genetics Inc
28/02/202409:00Business WireFulgent Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
13/02/202410:00Business WireFulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024NASDAQ:FLGTFulgent Genetics Inc
09/02/202420:09Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
09/02/202410:31PR Newswire (US)Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic TestingNASDAQ:FLGTFulgent Genetics Inc
12/12/202323:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FLGTFulgent Genetics Inc
14/11/202318:30Business WireFulgent to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:FLGTFulgent Genetics Inc
03/11/202317:05Business WireFulgent Shares Data from Two Poster Presentations at SITC 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
03/11/202308:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FLGTFulgent Genetics Inc
03/11/202308:00Business WireFulgent Reports Third Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
25/10/202309:00Business WireFulgent Announces Two Poster Presentations at SITC 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
17/10/202309:00Business WireFulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023NASDAQ:FLGTFulgent Genetics Inc
04/08/202308:00Business WireFulgent Reports Second Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
24/07/202317:05GlobeNewswire Inc.Exagen Inc. Appoints Paul Kim to Board of DirectorsNASDAQ:FLGTFulgent Genetics Inc
18/07/202309:00Business WireFulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023NASDAQ:FLGTFulgent Genetics Inc
06/06/202318:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLGTFulgent Genetics Inc
05/06/202309:30Business WireFulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various CancersNASDAQ:FLGTFulgent Genetics Inc
18/05/202317:59Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FLGTFulgent Genetics Inc
18/05/202317:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLGTFulgent Genetics Inc
18/05/202317:05Business WireFulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
05/05/202308:00Business WireFulgent Reports First Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
20/04/202317:05Business WireFulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023NASDAQ:FLGTFulgent Genetics Inc
11/04/202309:00PR Newswire (US)Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical ResearchNASDAQ:FLGTFulgent Genetics Inc
03/04/202307:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FLGTFulgent Genetics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FLGT

Seu Histórico Recente

TG
A28394
AB investor
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados